Evidence map›Paper›PMID 28045944›Full record

ArticlePloS one2017

Pharmaceutical Metabolism in Fish: Using a 3-D Hepatic In Vitro Model to Assess Clearance.

Matthew G Baron, Kate S Mintram, Stewart F Owen, Malcolm J Hetheridge, A John Moody, Wendy M Purcell, Simon K Jackson, Awadhesh N Jha

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Journal of pesticide science · 2020
    Article
  14. TPC2-mediated CaDevelopmental biology · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Matthew G BaronSchool of Biological Science, Plymouth University, Devon, United Kingdom.
Kate S MintramSchool of Biological Science, Plymouth University, Devon, United Kingdom.
Stewart F OwenAstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom.
Malcolm J HetheridgeAstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom.
A John MoodySchool of Biological Science, Plymouth University, Devon, United Kingdom.
Wendy M PurcellSchool of Biomedical & Healthcare Science, Plymouth University, Devon, United Kingdom.
Simon K JacksonSchool of Biomedical & Healthcare Science, Plymouth University, Devon, United Kingdom.
Awadhesh N JhaSchool of Biological Science, Plymouth University, Devon, United Kingdom.
AstraZeneca (United Kingdom) · GBUniversity of Plymouth · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At high internal doses, pharmaceuticals have the potential for inducing biological/pharmacological effects in fish. One particular concern for the environment is their potential to bioaccumulate and reach pharmacological levels; the study of these implications for environmental risk assessment has therefore gained increasing attention. To avoid unnecessary testing on animals, in vitro methods for assessment of xenobiotic metabolism could aid in the ecotoxicological evaluation. Here we report the use of a 3-D in vitro liver organoid culture system (spheroids) derived from rainbow trout to measure the metabolism of seven pharmaceuticals using a substrate depletion assay. Of the pharmaceuticals tested, propranolol, diclofenac and phenylbutazone were metabolised by trout liver spheroids; atenolol, metoprolol, diazepam and carbamazepine were not. Substrate depletion kinetics data was used to estimate intrinsic hepatic clearance by this spheroid model, which was similar for diclofenac and approximately 5 fold higher for propranolol when compared to trout liver microsomal fraction (S9) data. These results suggest that liver spheroids could be used as a relevant and metabolically competent in vitro model with which to measure the biotransformation of pharmaceuticals in fish; and propranolol acts as a reproducible positive control.

Indexed as

Drug Evaluation, PreclinicalAnimalsAtenololBiotransformationCarbamazepineDiazepamDiclofenacFemaleKineticsLiverMetoprololModels, AnimalOncorhynchus mykissPhenylbutazonePropranololTandem Mass SpectrometryAtenololCarbamazepineDiazepamDiclofenacMetoprololPhenylbutazonePropranololWater Pollutants, ChemicalXenobiotics

Identifiers

PMID28045944
PMCPMC5207725
OpenAlexW2571323631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.